Long-term outcomes of the viabahn stent in the treatment of in-stent restenosis in the superficial femoral artery

Journal of Invasive Cardiology

Volumn 25, Issue 12, 2013, Pages 670-674

  Gorgani, Farzan ^a   Telis, Anatoliy ^a   Narakathu, Niju ^a   Labarbera, Matthew ^a   Babaev, Anvar ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

In stent restenosis; superficial femoral artery; Viabahn stent

Indexed keywords

POLITEF;

AGED; ARTICLE; ATHERECTOMY; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; IN-STENT RESTENOSIS; LIMB ISCHEMIA; MALE; SELF EXPANDING STENT; SUPERFICIAL FEMORAL ARTERY; VIABAHN EXPANDABLE STENT; CASE CONTROL STUDY; CONSTRICTION, PATHOLOGIC; DEVICES; ENDOVASCULAR SURGERY; FEMORAL ARTERY; LONGITUDINAL STUDY; MIDDLE AGED; PATHOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL VASCULAR DISEASES; PROCEDURES; RECURRENT DISEASE; STENT; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, BALLOON; ATHERECTOMY; CASE-CONTROL STUDIES; CONSTRICTION, PATHOLOGIC; ENDOVASCULAR PROCEDURES; FEMALE; FEMORAL ARTERY; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; POLYTETRAFLUOROETHYLENE; RECURRENCE; STENTS; TREATMENT OUTCOME;

EID: 84890012803     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Schillinger M, Sabeti S, Loewe C, et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med. 2006;354(18):1879-1888. (Pubitemid 43872689)
2. Schillinger M, Sabeti S, Dick P, et al. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation. 2007;115(21):2745-2749. (Pubitemid 46842791)
3. Laird JR, Katzen BT, Scheinert D, et al. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv. 2010;3(3):267-276.
4. Zocholl G, Zapf S, Schild H, Thelen M. [Functional angiography of the arteries near the knee joint: consequences for stent implantation?]. Rofo. 1990;153(6):658-662.
5. Criqui MH, Fronek A, Barrett-Connor E, Klauber MR, Gabriel S, Goodman D. The prevalence of peripheral arterial disease in a defined population. Circulation. 1985;71(3):510-551.
6. Hiatt WR, Hoag S, Hamman RF. Effect of diagnostic criteria on the prevalence of peripheral arterial disease. The San Luis Valley Diabetes Study. Circulation. 1995;91(5):1472-1479.
7. Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation. 2004;110(6):738-743. (Pubitemid 39056275)
8. Saxon RR, Dake MD, Volgelzang RL, Katzen BT, Becker GJ. Randomized, multicenter study comparing expanded polytetrafluoroethylene-covered endoprosthesis placement with percutaneous transluminal angioplasty in the treatment of superficial femoral artery occlusive disease. J Vasc Interv Radiol. 2008;19(6):823-832. (Pubitemid 351713526)
9. Razzouk L, Aggarwal S, Gorgani F, Babaev A. In-stent restenosis in the superficial femoral artery. Ann Vasc Surg. 2013;27(4):510-524.
10. Biancari F, Albäck A, Ihlberg L, Kantonen I, Luther M, Lepäntalo M. Angiographic runoff score as a predictor of outcome following femorocrural bypass surgery. Eur J Vasc Endovasc Surg. 1999;17(6):480-485. (Pubitemid 29296747)
11. Ansel GM, Lumsden AB. Evolving modalities for femoropopliteal interventions. J Endovasc Ther. 2009;16(Suppl II):1182-1197.
12. Bauermeister G. Endovascular stent-grafting in the treatment of superficial femoral artery occlusive disease. J Endovasc Ther. 2001;8(3):315-320. (Pubitemid 32678744)
13. Jahnke T, Andresen R, Muller-Hulsbeck S, et al. Hemobahn stent-grafts for treatment of femoropopliteal arterial obstructions: midterm results of a prospective trial. J Vasc Intervent Radiol. 2003;14(1):41-51. (Pubitemid 36134073)
14. Lammer J, Dake MD, Bleyn J, et al. Peripheral arterial obstruction: prospective study of treatment with a transluminally placed self-expanding stent-graft. International Trial Study Group. Radiology. 2000;217(1):95-104. (Pubitemid 33097584)
15. Railo M, Roth WD, Edgren J, et al. Preliminary results with endoluminal femoropopliteal thrupass. Ann Chir Gynaecol. 2001;90(1):15-18.
16. Saxon RR, Coffman JM, Gooding JM, et al. Stent-graft use in the femoral and popliteal arteries. Tech Intervent Vasc Radiol. 2004;7(1):6-18.
17. Turicchia GU, Cevolani M, Altini R, et al. Mid-term results in PTFE endograft treatment of femoropopliteal occlusive disease. Osp Ital Chir. 2003;9:93-96.
18. Ansel GM, Geraghty PJ, Mewissen M, Jaff MR. 3-year VIBRANT results for bare stents and stent grafts in long SFA disease. Unpublished raw data.
19. Geraghty PJ. Covered stenting of the superficial femoral artery using the viabahn stent-graft. Perspect Vasc Surg Endovasc Ther. 2006;18(1):39-45.
20. Shammeri OA, Bitar F, Ghitelman J, Soukas PA. Viabahn for femoropopliteal in-stent restenosis. Ann Saudi Med. 2012;32(6):575-582.
21. Ansel GM, Lumsden AB. Evolving modalities for femoropopliteal interventions. J Endovasc Ther. 2009;16(2 Suppl 2):II82-II97.
22. Laird JR, Yeo KK, Rocha-Singh K et al. Excimer laser with adjunctive balloon angioplasty and heparin coated self-expanding stent grafts for the treatment of femoropopliteal artery in-stent restenosis: Twelve-month results from the SALVAGE study. Catheter Cardiovasc Interv. 2012;80(5):852-859.
23. Doomernik DE, Golchehr B, Lensvelt MM, Reijnen MM. The role of superficial femoral artery endoluminal bypass in long de novo lesions and in-stent restenosis. J Cardiovasc Surg (Torino). 2012;53(4):447-457.
24. Saxon RR, Coffman JM, Gooding JM, Ponec DJ. Long-term patency and clinical outcomes of the Viabahn stent-graft for femoropopliteal artery obstructions. J Vasc Interv Radiol. 2007;18(11):1341-1350.
25. Davies MG, Saad WE, Peden EK, Mohiuddin IT, Naoum JJ, Lumsden AB. Percutaneous Superficial Femoral Artery Interventions for Claudication-Does Runoff Matter? Ann Vasc Surg. 2008;22(6):790-798.
26. Ihnat DM, Duong ST, Taylor ZC, et al. Contemporary outcomes after superficial femoral artery angioplasty and stenting: the influence of TASC classification and runoff score. J Vasc Surg. 2008;47(5):967-974.
27. Davies MG, Saad WE, Peden EK, Mohiuddin IT, Naoum JJ, Lumsden AB. Impact of runoff on superficial femoral artery endoluminal interventions for rest pain and tissue loss. J Vasc Surg. 2008;48(3):619-626.
28. Dick P, Sabeti S, Mlekusch W et al. Conventional balloon angioplasty versus peripheral cutting balloon angioplasty for treatment of femoropopliteal artery in-stent restenosis: initial experience. Radiology. 2008;248(1):297-302.
29. Zeller T, Rastan A, Sixt S et al. Long-term results after directional atherectomy of femoropopliteal lesions. J Am Coll Cardiol. 2006;48(8):1573-1578. (Pubitemid 44528188)
30. Dake MD, Ansel GM, Jaff MR et al. Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: Twelve month Zilver PTX randomized study results. Circ Cardiovasc Interv. 2011;4(5):495-504.
31. Shin SH, Baril D, Chaer R, Makaroun M, Rhee R, Marone L. Cryoplasty offers no advantage over standard balloon angioplasty for the treatment of in-stent restenosis. J Vasc Surg. 2010;52(3):803-804.
32. Trani C, Burzotta F, Tommasino A, Giammarinaro M. Transradial approach to treat superficial femoral artery in-stent restenosis. Catheter Cardiovasc Interv. 2009;74(3):494-498.